Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Grassi

Showing results (41-50 of 808) with videos related to

Pageof 81
Sort By:
Acta Diabetologica|May 20, 2023
Response to the Letter regarding article "Heart rate threshold for cardiovascular risk and sympathetic activation in metabolic syndrome"Guido Grassi
Expert Opinion on Pharmacotherapy|November 6, 2012
Evaluation of the ASPIRANT trialGuido Grassi
American Journal of Hypertension|August 6, 2021
The Sympathetic Nervous System in Hypertension: Roadmap Update of a Long JourneyGuido Grassi
Current Hypertension Reviews|May 17, 2024
Highlights from the New European Society of Hypertension Guidelines DocumentGuido Grassi
Current Hypertension Reports|May 7, 2004
Leptin, sympathetic nervous system, and baroreflex functionGuido Grassi
Hypertension (Dallas, Tex. : 1979)|November 23, 2006
Adrenergic overdrive as the link among hypertension, obesity, and impaired thermogenesis: lights and shadowsGuido Grassi
American Journal of Hypertension|November 11, 2005
Sympathetic drive as a determinant of weight loss intervention outcome strengths and limitationsGuido Grassi
Journal of Hypertension|December 5, 2003
Involvement of neuroadrenergic factors in hypertensive vascular remodelling: myth or reality?Guido Grassi
Journal of Hypertension|May 17, 2005
Assessment of 24-h neuroadrenergic profile: does the dream come true?Guido Grassi
American Journal of Hypertension|February 19, 2016
Sympathomodulatory Effects of Antihypertensive Drug TreatmentGuido Grassi
Pageof 81

Showing results (41-50 of 808) with videos related to

Sort By:
Pageof 81
Acta Diabetologica|May 20, 2023
Response to the Letter regarding article "Heart rate threshold for cardiovascular risk and sympathetic activation in metabolic syndrome"Guido Grassi
Expert Opinion on Pharmacotherapy|November 6, 2012
Evaluation of the ASPIRANT trialGuido Grassi
American Journal of Hypertension|August 6, 2021
The Sympathetic Nervous System in Hypertension: Roadmap Update of a Long JourneyGuido Grassi
Current Hypertension Reviews|May 17, 2024
Highlights from the New European Society of Hypertension Guidelines DocumentGuido Grassi
Current Hypertension Reports|May 7, 2004
Leptin, sympathetic nervous system, and baroreflex functionGuido Grassi
Hypertension (Dallas, Tex. : 1979)|November 23, 2006
Adrenergic overdrive as the link among hypertension, obesity, and impaired thermogenesis: lights and shadowsGuido Grassi
American Journal of Hypertension|November 11, 2005
Sympathetic drive as a determinant of weight loss intervention outcome strengths and limitationsGuido Grassi
Journal of Hypertension|December 5, 2003
Involvement of neuroadrenergic factors in hypertensive vascular remodelling: myth or reality?Guido Grassi
Journal of Hypertension|May 17, 2005
Assessment of 24-h neuroadrenergic profile: does the dream come true?Guido Grassi
American Journal of Hypertension|February 19, 2016
Sympathomodulatory Effects of Antihypertensive Drug TreatmentGuido Grassi
Pageof 81